Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells. MSCs are of intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases. MSCs are advantageous over other stem cells types for a variety of reasons: they avoid the ethical issues that surround embryonic stem cell research, and repeated studies have found MSCs to be immuno-privileged, which make them an advantageous cell type for allogenic transplantation. MSCs reduce both the risks of rejection and complications of transplantation. Recently, there have been advances in the use of autologous mesenchymal stem cells to regenerate human tissues, including cartilage, meniscus, tendons, bone fractures, and more. View Detail Report With TOC At : http://www.researchmoz.us/mesenchymal-stem-cells-advances-and-applications-2013-report.html

1. Mesenchymal Stem Cells - Advances & Applications 2013
Understand and profit from the mesenchymal stem cell (MSC) product market – the fastest growing
area of stem cell research.
Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types,
including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially,
neuronal cells. MSCs are of intense therapeutic interest because they represent a population of cells with the
potential to treat a wide range of acute and degenerative diseases.
MSCs are advantageous over other stem cells types for a variety of reasons: they avoid the ethical issues that
surround embryonic stem cell research, and repeated studies have found MSCs to be immuno-privileged,
which make them an advantageous cell type for allogenic transplantation. MSCs reduce both the risks of
rejection and complications of transplantation. Recently, there have been advances in the use of autologous
mesenchymal stem cells to regenerate human tissues, including cartilage, meniscus, tendons, bone fractures,
and more.
Trend analysis of grant activity, scientific publication rates, and patent applications trends reveal that global
research activity involving mesenchymal stem cells (MSCs) increased 112% from 2009 to 2010, and 116%
from 2010 to 2011. Of most interest is that this rate of growth accelerated throughout 2011, making
mesenchymal stem cells the fastest growing area of stem cell research.
Because mesenchymal stem cell researchers represent a rapidly growing, well-funded research community,
this report presents strategies for research supply companies to use to develop high-demand products for this
community. A key element of this report is a survey of mesenchymal stem cell (MSC) researchers. This
survey reveals critical findings that include:
Preferred Tissue Source for MSCs Preferred Species Source for MSCs MSC Product Preferences Most
Commonly Utilized MSC Antibodies Terms Used in Online Search (for targeting your ads with precision) It
is also important for bio-pharmaceutical and pharma companies interested in mesenchymal stem cell therapy
applications to understand underlying market forces, and in particular, to consider progressive areas of MSC
research as opportunistic areas for drug and therapy development. This report presents a range of topics of
interest to these companies as well, including how advances in MSC research can reveal potential new drug
targets, improve methods of drug delivery, and provide personalized treatment strategies.
Highlights of this report include:
Charts, Timelines, Metrics and Financials Rates of MSC Grants, Publications, and Patents Market
Characterization and 5-Year Projections Breakdown of MSC Research Activity by Application, Species,
Tissue Source Geographical Assessment of Market Demand Competitive Environment Analysis, by MSC
Product Supplier Recent Product Evolution and Unmet Market Needs Online Advertising Assessment and
Opportunities for Targeted Traffic Revealing Survey of Your Prospective Clients MSC Scientists End-User
Wants, Technical Preferences, Factors Influencing Buying Decisions
And Much More...
The market intelligence contained in this report was compiled using a broad range of sources, including:
MSC grant funding (NIH database, DoD database) MSC patents (USPTO) MSC publications (PubMed,
Highwire Press) MSC product launch announcements (Google News, Trade Journals) International surveys
(electronically distributed end-user surveys) And more
Mesenchymal Stem Cells - Advances & Applications 2013

2. These sources were used to identify recent advances in MSC research applications, explore research priorities
by market segment, highlight individual labs and end-users of MSC research products, explore the competitive
environment for MSC research products, and provide 5-year growth and trend analysis. As such, this market
intelligence report will advantageously position your company to offer competitive MSC products to this
rapidly growing, well-funded research community.
You'll also access information on:
Recent Product Evolution Projected Directions for Development Overview of Therapeutic Progress and
Insight into Future Applications Detailed Evaluation of Profit Opportunities for Research Product Suppliers
In summary, literature and data concerning the biology and differentiation potential of mesenchymal stem
cells (MSCs) has become huge in less than 10 years, now totaling nearly 13,000 publications, although some
data does present as contradictory, suggesting a heterogenic nature for MSC populations depending on source
tissue, species, and donor characteristics. MSCs appear to be an exceptionally promising tool for cell therapy
because of their unusual characteristics, which partially mimic those of embryonic stem cells, but have
advantages in terms of availability, expandability, transplantability, and ethical implications.
Interest in therapeutic applications of human MSCs arises from their diverse ability to differentiate into a
range of cell types, as well as from their ability to migrate to sites of tissue injury/inflammation or tumor
growth. These localization properties present a promising strategy for targeted introduction of therapeutic
agents through MSC gene therapy. In addition, MSCs possess strong immunosuppressive properties that
medical researchers are exploiting for both autologous as well as heterologous therapies.
Characterized by these properties, it not surprising that trend analysis reveals rapid increases in research
activity involving mesenchymal stem cells. With scientific publication rate increases of 112% year-over-year
from 2009 to 2010, and 116% from 2010 to 2011, this report will help you understand and profit from the
mesenchymal stem cell (MSC) product market – the fastest growing area of stem cell research.
table Of Content
i. Abstract
ii. Overview
a. Definition
b. Alternative Nomenclature
c. Identification
1. Characteristics
2. Functional Attributes
d. Benefits Relative To Other Stem Cell Types
iii. Sources
a. Fetal
b. Adult
Mesenchymal Stem Cells - Advances & Applications 2013

3. iv. Cell Types Derived From Mscs
v. Applications
a. Basic Research Applications
1. Directed Differentiation Of Autologous Mscs To Intra-mesenchymal Lineages
2. Directed Differentiation Of Autologous Mscs To Extra-mesenchymal Lineages
b. Supporting Hematopoietic Cells
c. Gene Transfer Applications
d. Cell Transplantation For Site-specific Repair
1. Overview
2. Major Applications
a. Osteogenic-focused Research Labs
b. Myogenic And Myocardial Repair
c. Neural Repair
c. Pancreatic Repair
e. Topical Therapy And Use Of Mscs In Wound Healing
f. Use Of Msc In 3-d Scaffolds For Tissue Engineering Applications
g. Drug Delivery Applications: Engineered Mscs As Carriers Of Anti-cancer Drugs
h. Drug Screening
i. Msc-mediated Inhibition Of Immune Effector Cells
vi. Application Priorities
a. Overall
b. By Segment
1. Academic
2. Biotechnology
3. Pharmaceutical
vii. Companies Offering Human Msc Research Products
a. Abcam
b. Bd Biosciences
c. Celprogen
d. Cyagen Biosciences (china Only)
e. Invitrogen
f. Lgc Standards/atcc
g. Lonza
h. Millipore
i. Miltenyi Biotec
j. Paa - The Cell Culture Company
k. Promocell
Mesenchymal Stem Cells - Advances & Applications 2013

4. l. Sa Biosciences
m. Sciencell Research Laboratories
n. Stemcelltechnologies
o. Thermo Scientific
p. R&d Systems
viii. Companies Offering Rodent Msc Research Products
(note: Eight Companies Currently Offer Rat Msc Products: Cell Applications, Celprogen, Cyagen
Biosciences, Genlantis, Millipore, Miltenyi Biotec, Sciencell Research Laboratories, And Trevigen.)
however, Five Were Profiled In The Previous Section, Leaving Three To Profile Below As Limited Providers
Of Rat Msc Products.)
a. Cell Applications
b. Genlantis
c. Trevigen
ix. Analysis Of Msc Research Activity
a. By Tissue Source Of Origin
b. By Clinical Application
c. By Species Source
d. By Geographical Region
x. Market Trend Analysis
a. Scientific Publication Rate Analysis
1. Historical 10-year Analysis
2. Future Five-year Projection
b. Grant Trend Rate Analysis
1. Historical 10-year Analysis
2. Future Five-year Projection
c. Patent Analysis
xi. Mesenchymal Stem Cells As Tools For Drug Discovery
a. Companies Developing Toxicology Screening Platforms For Stem Cells
b. Potential Drug Screening Advantages Of Mouse Mscs
1. Acquisition, Handling, And Differentiation Advantages
2. Genetic Manipulation Of Mscs
3. Potential For Genetically Engineered Msc Reporter Lines
xii. Serum Free Supplements For Use In Msc Research
Mesenchymal Stem Cells - Advances & Applications 2013

5. a. Invitrogen, Inc.
b. Celprogen
c. Millipore, Inc.
d. Stem Cell Technologies
e. Us Patent 7109032: Serum-free Medium For Mesenchymal Stem Cells (genoa, It)
xiii. End-user Preferences (scientist Panel)
a. Source Preference
b. Species Preference
c. Msc Product Preferences
d. Most Commonly Used Msc Antibodies
e. Common Terms Used For Online Product Search
xiv. Research Product Opportunities And Suggestions
a. Rat Mscs Derived From Synovium
b. Novel Msc Differentiation Kits
c. Mesenchymal Stem Cell Expansion Media
d. Antibodies To Mesenchymal Stem Cell Markers
e. Mesenchymal Growth Factors
f. Monoclonal Antibodies And Kits For Phenotyping Mscs
g. Chips For Microarray Analysis Of Gene Expression In Mscs
xv. Potential Labs/customers
a. General Msc Research Labs
b. Osteogenic-focused Research Labs
c. Myogenic- And Myocardial-focused Research Labs
d. Adipogenic-focused Research Labs
e. Neuronal-focused Research Labs
f. Immunology-focused Research Labs
g. National Institutes Of Health (nih) Labs
h. Commercial Labs
xvi. Conclusions
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
Mesenchymal Stem Cells - Advances & Applications 2013

6. which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Mesenchymal Stem Cells - Advances & Applications 2013